1-164559914-G-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_StrongBP6_ModerateBS1BS2
The NM_002585.4(PBX1):c.92G>T(p.Gly31Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000982 in 1,548,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G31S) has been classified as Likely benign.
Frequency
Consequence
NM_002585.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000520 AC: 79AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000590 AC: 9AN: 152476Hom.: 0 AF XY: 0.0000371 AC XY: 3AN XY: 80826
GnomAD4 exome AF: 0.0000516 AC: 72AN: 1396114Hom.: 0 Cov.: 38 AF XY: 0.0000450 AC XY: 31AN XY: 688618
GnomAD4 genome AF: 0.000526 AC: 80AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000511 AC XY: 38AN XY: 74394
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
The PBX1 p.Gly31Val variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs192264696) and was also found in control databases in 26 of 183832 chromosomes at a frequency of 0.000141 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 23 of 16644 chromosomes (freq: 0.001382), Other in 1 of 5326 chromosomes (freq: 0.000188), Latino in 1 of 25216 chromosomes (freq: 0.00004) and European (non-Finnish) in 1 of 74156 chromosomes (freq: 0.000013), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Gly31 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at